Skip to main content

Advertisement

Table 1 Patients characteristics, N = 100

From: Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan

Characteristics Number (%)
Age
 Median (years) 40
 Range (years) 22–75
Pathology
 IDC 91 (91%)
 ILC and others 9 (9%)
Stage
 I 16 (16%)
 II 51 (51%)
 III 22 (22%)
 IV 2 (2%)
Unknown 9 (9%)
Grade
 I 10 (10%)
 II 37 (37%)
 III 45 (45%)
Unknown 8 (8%)
Hormone Receptor Status
 ER and/or PR Positive 77 (77%)
 ER Positive 77 (77%)
 ER Negative 22 (22%)
 ER Unknown 1 (1%)
 PR Positive 77 (77%)
 PR Negative 22 (22%)
 PR Unknown 1 (1%)
HER-2 Status
 Positive 13 (13%)
 Negative 80 (80%)
 Unknown 7 (7%)
Triple-Negative 17 (17%)
  1. IDC Infiltrating Ductal Carcinoma, ILC Infiltrating Lobular Carcinoma